Walker on Progress

ALK appoints veteran Edward Jordan, elevating its North American operations to drive a strategic market offensive in the competitive allergy space.

As AI transforms drug discovery, access to GPU power is critical. A new hybrid model from Hydaway Digital could unlock speed and efficiency for pharma R&D.

Medical Facilities Corp. renews its share buyback, a bold move signaling undervaluation. But does this strategy signal growth or just financial engineering?

A leadership shake-up at a top logistics firm reveals a push for digital transformation. What does this mean for the future of the pharma supply chain?

A Thanksgiving greeting from a clean tech firm reveals a strategic dividend. We dissect how microcaps use narration to drive momentum in high-risk sectors.

Successful long-term toxicology data for HER-096 builds on Phase 1b success, solidifying its path to a pivotal Phase 2 trial for Parkinson's disease.

A new venture pioneers Tesla's business program, blending high-speed charging with lifestyle hubs. Is Suncoast Charging's model the future of EV networks?

A new AI tool in the timeshare exit industry offers a blueprint for how technology can combat fraud and empower consumers in complex, regulated markets.

EV charging firm Tellus Power recruits a UK political heavyweight. Is this the key to unlocking Europe's complex smart grid market and V2G technology?

Sodexo taps veteran Joe Ganci to lead a critical U.S. turnaround, signaling a strategic shift to redefine the workplace experience for its corporate clients.

A top renewable energy firm's sustainability score offers a powerful lesson for pharma: robust ESG isn't just a metric, it's a strategic asset for growth.

As Halozyme preps for the Evercore conference, we dissect the strategy behind its ENHANZE® royalty engine and new Hypercon™ tech reshaping drug delivery.

A key industrial landlord in Southern California adds a capital allocation expert to its board. Here's why pharma leaders should be paying close attention.

CRB appoints a proven growth driver to lead preconstruction, signaling the rising importance of early-stage planning in advanced facility project delivery.

Kate McAfoose's dual Gold Stevie® wins aren't just personal honors; they signal a market shift towards automation that empowers people and solves real-world crises.

Lennar's oversubscribed exchange offer for its Millrose stake is complete. We analyze the strategic pivot and what the proration puzzle means for investors.

Versant Ventures' new startup, Dayra Therapeutics, secures a major Biogen deal, validating its platform to create pill-based biologics for immunology.

A modest $350K private placement reveals Vaxil Bio's deep identity crisis as it looks beyond its orphan drug asset for a new path to survival.

Céline Gerson's appointment to Enerflex's board signals a strategic push in global markets and energy transition. What does her unique expertise mean?

As a 43-day government shutdown roiled federal families, one firm’s $10M intervention highlights a new strategic playbook for corporate responsibility.